Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature.
Grisanti S, Ferrari VD, Buglione M, Agazzi GM, Liserre R, Poliani L, Buttolo L, Gipponi S, Pedersini R, Consoli F, Panciani P, Roca E, Spena G, Triggiani L, Berruti A; Gruppo Neuro-Oncologico Bresciano. Grisanti S, et al. Among authors: triggiani l. J Neurosurg Sci. 2019 Aug;63(4):458-467. doi: 10.23736/S0390-5616.16.03874-1. Epub 2016 Sep 28. J Neurosurg Sci. 2019. PMID: 27680966
The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.
Buglione M, Bandera L, Grisanti S, Pasinetti N, Borghetti P, Barbera F, Triggiani L, Costa L, Shehi B, Bonetti B, Magrini S. Buglione M, et al. Among authors: triggiani l. Radiol Med. 2012 Feb;117(1):133-47. doi: 10.1007/s11547-011-0738-x. Epub 2011 Oct 21. Radiol Med. 2012. PMID: 22020431 English, Italian.
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group.
Buglione M, Borghetti P, Pedretti S, Triggiani L, Fontanella MM, Spena G, Grisanti S, Liserre R, Poliani LP, Gipponi S, Spiazzi L, Magrini SM. Buglione M, et al. Among authors: triggiani l. Radiol Med. 2015 Oct;120(10):975-81. doi: 10.1007/s11547-015-0528-y. Epub 2015 Mar 15. Radiol Med. 2015. PMID: 25773653
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.
Buglione M, Pedretti S, Gipponi S, Buttolo L, Panciani P, Poliani PL, Liserre R, Borghetti P, Pegurri L, Costa L, Triggiani L, Pasinetti N, Ghirardelli P, Pandini S, Padovani A, Magrini SM; Neuro-Oncology Group, Spedali Civili Hospital and Brescia University. Buglione M, et al. Among authors: triggiani l. Radiol Med. 2015 Dec;120(12):1146-52. doi: 10.1007/s11547-015-0542-0. Epub 2015 Apr 28. Radiol Med. 2015. PMID: 25917339
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program.
Buglione M, Ghirardelli P, Triggiani L, Pedretti S, Pasinetti N, De Bari B, Tonoli S, Borghetti P, Spiazzi L, Magrini SM. Buglione M, et al. Among authors: triggiani l. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):284-91. doi: 10.1016/j.rpor.2015.03.003. Epub 2015 Apr 8. Rep Pract Oncol Radiother. 2015. PMID: 26109916 Free PMC article.
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Magrini SM, et al. Among authors: triggiani l. J Clin Oncol. 2016 Feb 10;34(5):427-35. doi: 10.1200/JCO.2015.63.1671. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644536 Clinical Trial.
117 results